Article info
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0152: Weekly Docetaxel and Irinotecan in Platinum-Refractory and Resistant Ovarian Cancer: a Phase II Study of the Austrian Ago
Citation
0152: Weekly Docetaxel and Irinotecan in Platinum-Refractory and Resistant Ovarian Cancer: a Phase II Study of the Austrian Ago
Online issue publication
December 03, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2006 IGCS, International Journal of Gynecological Cancer